Uranus Chemicals Balance Sheet Health
Financial Health criteria checks 4/6
Uranus Chemicals has a total shareholder equity of NT$1.7B and total debt of NT$447.3M, which brings its debt-to-equity ratio to 26.8%. Its total assets and total liabilities are NT$2.7B and NT$1.0B respectively. Uranus Chemicals's EBIT is NT$105.3M making its interest coverage ratio 101.4. It has cash and short-term investments of NT$331.4M.
Key information
26.8%
Debt to equity ratio
NT$447.31m
Debt
Interest coverage ratio | 101.4x |
Cash | NT$331.44m |
Equity | NT$1.67b |
Total liabilities | NT$1.03b |
Total assets | NT$2.69b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 7742's short term assets (NT$966.6M) exceed its short term liabilities (NT$694.0M).
Long Term Liabilities: 7742's short term assets (NT$966.6M) exceed its long term liabilities (NT$331.6M).
Debt to Equity History and Analysis
Debt Level: 7742's net debt to equity ratio (6.9%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if 7742's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 7742's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 7742's interest payments on its debt are well covered by EBIT (101.4x coverage).